Skip to content
Disclosery

EXANE DERIVATIVES: HPE position timeline

Available 13F reports, 13D and 13G stakes and each Form 3, 4 and 5 line of EXANE DERIVATIVES on HPE, newest first. How the timeline and the estimate are built.

EXANE DERIVATIVES held 67,409 HPE shares at 2022-06-30 per its 13F-HR filed 2022-07-12.

the latest 13F is the newest step

  1. period ended2022-06-30
    13F 67,409 shares
    Change vs previous 13F +32,132 shares

    0.51% of the 13F portfolio, value $893,749.

    13F-HR 0001623883-22-000006 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  2. period ended2022-03-31
    13F 35,277 shares
    Change vs previous 13F -15,056 shares

    0.17% of the 13F portfolio, value $589,467.

    13F-HR 0001623883-22-000004 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  3. period ended2021-12-31
    13F 50,333 shares
    Change vs previous 13F +1,013 shares

    0.19% of the 13F portfolio, value $793,755.

    13F-HR 0001623883-22-000002 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  4. period ended2021-09-30
    13F 49,320 shares
    Change vs previous 13F +48,197 shares

    0.18% of the 13F portfolio, value $702,814.

    13F-HR 0001623883-21-000008 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  5. period ended2021-06-30
    13F 1,123 shares
    Change vs previous 13F -4,770 shares

    <0.01% of the 13F portfolio, value $15,453.

    13F-HR 0001623883-21-000006 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  6. period ended2021-03-31
    13F 5,893 shares
    Change vs previous 13F +5,717 shares

    0.03% of the 13F portfolio, value $92,756.

    13F-HR 0001623883-21-000004 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  7. period ended2020-12-31
    13F 176 shares
    Change vs previous 13F 0 shares

    <0.01% of the 13F portfolio, value $2,086.

    13F-HR 0001623883-21-000002 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  8. period ended2020-09-30
    13F/A 176 shares
    Change vs previous 13F not available

    <0.01% of the 13F portfolio, value $1,649.

    13F-HR/A 0001623883-20-000010 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).